Bioavailability Challenge

Inflammasome develops combo HIV/birth control implant

23-Aug-2021 By Jenni Spinner

Thanks in part to grants from the Gates Foundation, the company has come up with a bioerodible implant that combines HIV prevention and birth control.

Hot-melt extrusion can improve bioavailability: Avomeen

14-Jun-2021 By Jenni Spinner

With bioavailability challenges a frequent frustration for drug developers, one research outfit suggests a technique that could reduce the headaches.

Online HPAPI Summit takes on key pharma ingredients topics

19-May-2021 By Jenni Spinner

The virtual event (scheduled June 22-24) will feature presentations from Bayer, Merck, GSK, Novartis, Takeda, FDA, WHO, and other notable organizations.

Lonza leader outlines small-molecule trends for 2021 and beyond

06-May-2021 By Jenni Spinner

The head of small-molecule business for the pharma solutions specialist talks about obstacles, and how companies can work to clear them for future success.

Lonza expands solid-form services at Oregon facility

01-Mar-2021 By Jenni Spinner

The company has increased capabilities at its Bend, Oregon location, including its SimpliFiH Solutions first-in-human services for small-molecule drugs.

Lexaria broadens COVID-19 drug exploration program

11-Jan-2021 By Jenni Spinner

The drug delivery platform company is exploring the viability of remdesivir and other potential treatments for the virus using its DehydraTECH technology.

Sandoz incorporates RFID technology on injectables

20-Oct-2020 By Jenni Spinner

The generic drug manufacturer is working with Kit Check to incorporate the company's drug supply-chain management technology into two of its products.

CPhI Festival of Pharma

CPhI: Dramatic changes ahead for the generics market

12-Oct-2020 By Jenni Spinner

Technology impacting generic drugs include artificial intelligence, telemedicine, fraud-preventing digital solutions and more, according to a report

TFF, Union Therapeutics join on potential COVID-19 treatment

27-Aug-2020 By Jenni Spinner

The companies will partner on developing dry-powder forms of niclosamide as a treatment for the virus, using thin-film freezing technology.

Webinar delves into drug delivery innovations

09-Jul-2020 By Jenni Spinner

Innovations in Drug Delivery Part II, a free online event on July 15, will feature novel technologies and innovative solutions to current challenges.

Takeda taps Evox for exosome therapeutics

30-Mar-2020 By Ben Hargreaves

The partners will focus on developing five potential exosome treatment for rare diseases.

Formulation method improves bioavailability of poorly soluble molecules

09-Mar-2020 By Vassia Barba

Orion to benefit from Nanoform’s formulation technology, which is able to improve bioavailability and solubility of early-stage compounds.

FDA approves biodegradable implant for eye conditions

09-Mar-2020 By Ben Hargreaves

Allergan’s intracameral sustained-release implant receives US FDA approval for two indications treating ophthalmic conditions.

Merck KGaA partners on 3D-printed tablets manufacture

27-Feb-2020 By Vassia Barba

Merck to produce 3D-printed tablets by tapping into the technology developed by AMCM, making a move towards digitalization.

Formulation technology improving CBD uptake bought out

20-Feb-2020 By Vassia Barba

Bioavailability of water insoluble compounds, such as CBD, enhanced up to 15 times with the technology of Solmic, leading to its acquisition by Betterlife.